Kaposi’s Sarcoma-Associated Herpesvirus Transmission RFA
For more information about this potential funding opportunity, please check out the Office of HIV and AIDS Malignancy’s presentation of the FOA Concept to the Board of Scientific Advisors on …
16th International Conference on Malignancies in HIV/AIDS
This meeting is presented by the Office of HIV and AIDS Malignancy, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services will take place October …
59th American Society of Hematology Annual Meeting & Exposition
Come Visit Us at ASH 2017 from December 9-12 held at the Georgia World Congress Center Booth #1740
Tenure Eligible/Tenure Track Position in the HIV and AIDS Malignancy Branch (HAMB)
The HIV and AIDS Malignancy Branch (HAMB) is seeking a tenure-eligible or tenure-track investigator in the field of HIV–related malignancies or viral oncogenesis. (READ MORE)
Global Oncology Young Investigator Award (YIA)
The Conquer Cancer Foundation (CCF) of ASCO is accepting applications for the inaugural 2018 Global Oncology Young Investigator Award (YIA). The one-year grant provides research funding to early-career investigators to …
ACSR JAMA Oncology Abstract
Yanik EL, Kaunitz GJ, Cottrell TR, Succaria F, McMiller TL, Ascierto ML, Esandrio J, Xu H, Ogurtsova A, Cornish T, Lipson EJ, Topalian SL, Engels EA, Taube JM. Association of …
ACSR PLOS ONE Publication
Yakovleva A, Plieskatt JL, Jensen S, Humeida R, Lang J, et al. (2017) Fit for genomic and proteomic purposes: Sampling the fitness of nucleic acid and protein derivatives from formalin fixed paraffin embedded tissue. PLOS ONE …
R01 Research Project Grant
The purpose of this Funding Opportunity Announcement (FOA) is to advance our understanding of the role of the tumor niche or microenvironment in the risks, development, progression, diagnosis, and treatment …
20th International Workshop on Kaposi’s Sarcoma Herpes Virus and Related Agents
25–28 July 2017 • Berlin, Germany(READ MORE)
9th International AIDS Society Conference
The Paris Statement: HIV Science MattersEnding the epidemic requires the continued contribution of and investment in science.(READ MORE)